• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致心律失常性右室心肌病/发育不良患者中心力衰竭较为常见但常被漏诊。

Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.

机构信息

From the Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD (N.A.G., A.B., C.A.J., B.M., C.T., C.S.O., D.P.J., S.D.R., H.C., R.J.T.); Division of Cardiology, University Medical Center Utrecht, The Netherlands (A.S.J.t.R.); and Division of Cardiology, Department of Medicine, University at Buffalo, State University of New York (A.S.).

出版信息

Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.116.003819.

DOI:10.1161/CIRCHEARTFAILURE.116.003819
PMID:28874384
Abstract

BACKGROUND

Heart failure (HF) prevalence in arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) varies depending on study cohort and is not well characterized. This study sought to determine prevalence and predictors of HF in ARVC/D.

METHODS AND RESULTS

Clinical HF, defined as at least 1 HF sign or symptom, was retrospectively adjudicated for 289 patients meeting ARVC/D Task Force Criteria. HF was present in 142 patients (49%): 113 had isolated RV involvement and 29 had evidence of LV dysfunction. Average age of HF onset was 40±14 years. Most commonly reported symptoms were exertional dyspnea (78%) and fatigue (73%). Only 40% (n=57/142) had signs of volume overload. Left-sided HF signs were rare. Patients with clinical HF before ARVC/D diagnosis (n=31) were older (=0.005) and met fewer Task Force Criteria (=0.013) than those who developed HF after ARVC/D presentation. Female sex (odds ratio, 2.2; 95% confidence interval, 1.21-4.01; =0.01) and lateral precordial T-wave inversions (odds ratio, 9.87; 95% confidence interval, 1.07-91.1; =0.043) were associated with increased odds of HF. Additionally, patients with symptomatic LV dysfunction had higher odds of lateral precordial T-wave inversions (odds ratio, 18.4; 95% confidence interval, 2.92-116.18; =0.002). Patients with HF were more likely to undergo heart transplantation (15/142 versus 1/147; <0.001) or die during study follow-up period (7 versus 0; =0.007).

CONCLUSIONS

HF symptoms, especially exertional dyspnea, are common in ARVC/D; yet, classic left-sided signs are typically absent and less than half have evidence of volume overload. Given the unique predominately right-sided phenotype, a large portion of patients with HF may be under-recognized.

摘要

背景

心律失常性右室心肌病/发育不良(ARVC/D)的心力衰竭(HF)患病率因研究队列而异,且尚未得到充分描述。本研究旨在确定 ARVC/D 中 HF 的患病率和预测因素。

方法和结果

临床 HF 定义为至少有 1 项 HF 体征或症状,对符合 ARVC/D 工作组标准的 289 例患者进行了回顾性判定。142 例患者(49%)存在 HF:113 例为单纯 RV 受累,29 例存在 LV 功能障碍证据。HF 发病的平均年龄为 40±14 岁。最常报告的症状是劳力性呼吸困难(78%)和疲劳(73%)。仅有 40%(n=57/142)存在容量超负荷的体征。左侧 HF 体征罕见。在 ARVC/D 诊断前发生临床 HF(n=31)的患者比在 ARVC/D 表现后发生 HF 的患者年龄更大(=0.005),且符合的工作组标准更少(=0.013)。女性(比值比,2.2;95%置信区间,1.21-4.01;=0.01)和外侧胸前区 T 波倒置(比值比,9.87;95%置信区间,1.07-91.1;=0.043)与 HF 发生的可能性增加相关。此外,有症状的 LV 功能障碍患者更有可能出现外侧胸前区 T 波倒置(比值比,18.4;95%置信区间,2.92-116.18;=0.002)。HF 患者更有可能在研究随访期间接受心脏移植(15/142 例 vs. 1/147 例;<0.001)或死亡(7 例 vs. 0 例;=0.007)。

结论

ARVC/D 中 HF 症状,尤其是劳力性呼吸困难,较为常见;然而,典型的左侧体征通常不存在,且不到一半的患者存在容量超负荷的证据。鉴于其独特的主要右侧表型,很大一部分 HF 患者可能未被充分识别。

相似文献

1
Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.致心律失常性右室心肌病/发育不良患者中心力衰竭较为常见但常被漏诊。
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.116.003819.
2
Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?致心律失常性右室心肌病患者的心力衰竭:危险因素有哪些?
Int J Cardiol. 2017 Aug 15;241:288-294. doi: 10.1016/j.ijcard.2017.04.061. Epub 2017 Apr 21.
3
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria.区分符合 2010 年 ARVC 工作组标准的遗传性心律失常性右心室心肌病与心脏结节病。
Heart Rhythm. 2021 Feb;18(2):231-238. doi: 10.1016/j.hrthm.2020.09.015. Epub 2020 Sep 22.
4
Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.沙特阿拉伯的致心律失常性右室心肌病/发育异常:一项长期随访的单中心经验
Ann Saudi Med. 2014 Sep-Oct;34(5):415-26. doi: 10.5144/0256-4947.2014.415.
5
Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.功能性右心室参数在致心律失常性右心室心肌病/发育不良中的预后价值不同。
Circ Cardiovasc Imaging. 2014 Mar;7(2):230-9. doi: 10.1161/CIRCIMAGING.113.000210. Epub 2014 Feb 10.
6
Unusual Serial Electrocardiographic Changes which Progressed to Arrhythmogenic Right Ventricular Cardiomyopathy.进展为致心律失常性右室心肌病的不寻常系列心电图改变
Intern Med. 2016;55(9):1103-8. doi: 10.2169/internalmedicine.55.5976. Epub 2016 May 1.
7
Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging.修订后的工作组标准的影响:使用心脏磁共振成像区分运动员心脏与 ARVC/D。
Eur J Prev Cardiol. 2012 Aug;19(4):885-91. doi: 10.1177/1741826711414215. Epub 2011 Jun 20.
8
High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.心律失常性右室心肌病/发育不良中与桥粒芯糖蛋白-2 突变相比,桥粒斑蛋白-2 突变与心力衰竭风险增加相关。
Eur J Heart Fail. 2019 Jun;21(6):792-800. doi: 10.1002/ejhf.1423. Epub 2019 Feb 21.
9
Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.晚期就诊的致心律失常性右心室心肌病/发育不良患者的心脏表型和长期预后
Heart Rhythm. 2017 Jun;14(6):883-891. doi: 10.1016/j.hrthm.2017.02.013. Epub 2017 Feb 12.
10
Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.碎裂QRS波群可预测致心律失常性右室心肌病/发育不良患者的心律失常事件。
J Cardiovasc Electrophysiol. 2013 Nov;24(11):1260-6. doi: 10.1111/jce.12202. Epub 2013 Jul 11.

引用本文的文献

1
Heart Transplant and Durable Mechanical Circulatory Support for Specific Less-Common Cardiomyopathies.特定罕见心肌病的心脏移植和持久性机械循环支持
CJC Open. 2025 Mar 24;7(6):813-820. doi: 10.1016/j.cjco.2025.03.015. eCollection 2025 Jun.
2
China Multi-Center Cohort Study on Risk Evaluation of Arrhythmogenic Cardiomyopathy: The ChinaCORE ACM Registry.中国致心律失常性心肌病风险评估多中心队列研究:中国CORE-ACM注册研究
JACC Asia. 2025 Jul;5(7):914-923. doi: 10.1016/j.jacasi.2025.04.005. Epub 2025 May 10.
3
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies.
热射病性心肌病:病理生理学、诊断挑战及新兴疗法
Curr Cardiol Rep. 2025 Jan 9;27(1):11. doi: 10.1007/s11886-024-02168-6.
4
Case report: Additional variants induced sudden cardiac death among pediatric ACM with homozygous mutant genotype: a report of three cases.病例报告:纯合突变基因型小儿致心律失常性右室心肌病中其他变异导致的心源性猝死:三例报告
Front Genet. 2024 Aug 26;15:1428796. doi: 10.3389/fgene.2024.1428796. eCollection 2024.
5
A Territory-Wide Study of Arrhythmogenic Right Ventricular Cardiomyopathy Patients from Hong Kong.一项针对香港致心律失常性右室心肌病患者的全港性研究。
Rev Cardiovasc Med. 2022 Jun 24;23(7):231. doi: 10.31083/j.rcm2307231. eCollection 2022 Jul.
6
The Challenges of Diagnosis and Treatment of Arrhythmogenic Cardiomyopathy: Are We there yet?致心律失常性心肌病的诊断与治疗挑战:我们做到了吗?
Rev Cardiovasc Med. 2022 Aug 15;23(8):283. doi: 10.31083/j.rcm2308283. eCollection 2022 Aug.
7
Exploring the Therapeutic Potential of Gene Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy.探索基因治疗在致心律失常性右室心肌病中的治疗潜力。
Biomedicines. 2024 Jun 18;12(6):1351. doi: 10.3390/biomedicines12061351.
8
Endurance Training Provokes Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Heterozygous Desmoglein-2 Mutants: Alleviation by Preload Reduction.耐力训练诱发杂合型桥粒芯糖蛋白-2突变体出现致心律失常性右室心肌病表型:通过降低前负荷缓解
Biomedicines. 2024 Apr 30;12(5):985. doi: 10.3390/biomedicines12050985.
9
Management Strategies in Arrhythmogenic Cardiomyopathy across the Spectrum of Ventricular Involvement.致心律失常性心肌病全谱心室受累的管理策略
Biomedicines. 2023 Dec 9;11(12):3259. doi: 10.3390/biomedicines11123259.
10
The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview.致心律失常性心肌病的多面性:概述
Appl Clin Genet. 2023 Nov 1;16:181-203. doi: 10.2147/TACG.S383446. eCollection 2023.